Anthony Repay is currently serving as Laboratory Director of Method Testing Laboratories in Tampa, FL. Anthony started his career as the head food and environmental microbiologist at a Chicago-based testing laboratory before joining the cannabis science community. Since joining cannabis, Anthony has tried to innovate and push the cannabis microbiology community by publishing peer-reviewed papers, speaking on proper quality control and volunteering in several national wide cannabis groups. 
During our conversation we discuss:

How growers can incorporate microbial testing into their processes 
Sources of microbial contamination and tips for prevention 
How differences in microbial regulations influence growers in certain states 
Remediation technologies 
and more 

Thanks to This Episode’s Sponsor: RS BioTherapeutics 
RS BioTherapeutics’ first investigational compound (RSBT-001) is a nebulized, semi-synthetic, cannabidiolic acid complex in development to address exacerbation and prevent progression of both acute and chronic pulmonary inflammation related to respiratory diseases including COPD, SARS-COV-2, Cystic Fibrosis, Asthma, Bronchitis, and Acute Respiratory Distress Syndrome. More information on RS BioTherapeutics can be found at www.rsbiotherapeutics.com.
Additional Resources

Anthony Repay on LinkedIn
Method Testing Laboratories website
Cannabis Microbial Testing Regulations by State [Interactive Tool]
Request an Invitation to CannMed 23
Review the Podcast!
CannMed Archive
CannMed Community Board [Facebook Group]
Healthcare Provider Medical Cannabis Research Study

Ver todos los episodios